Zymeworks, Inc. (ZYME)
28.77
+0.10
(+0.35%)
USD |
NASDAQ |
Aug 24, 16:00
29.95
+1.18
(+4.10%)
After-Hours: 06:36
Zymeworks Shareholders Equity (Quarterly) : 80.37M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 80.37M |
| March 31, 2026 | 163.59M |
| December 31, 2025 | 268.50M |
| September 30, 2025 | 320.06M |
| June 30, 2025 | 334.51M |
| March 31, 2025 | 324.97M |
| December 31, 2024 | 338.77M |
| September 30, 2024 | 366.98M |
| June 30, 2024 | 406.16M |
| March 31, 2024 | 438.00M |
| December 31, 2023 | 464.81M |
| September 30, 2023 | 424.34M |
| June 30, 2023 | 448.92M |
| March 31, 2023 | 473.54M |
| December 31, 2022 | 492.96M |
| September 30, 2022 | 179.76M |
| June 30, 2022 | 222.28M |
| March 31, 2022 | 282.44M |
| December 31, 2021 | 249.09M |
| Date | Value |
|---|---|
| September 30, 2021 | 278.93M |
| June 30, 2021 | 321.47M |
| March 31, 2021 | 377.14M |
| December 31, 2020 | 409.92M |
| September 30, 2020 | 432.35M |
| June 30, 2020 | 491.25M |
| March 31, 2020 | 522.42M |
| December 31, 2019 | 245.68M |
| September 30, 2019 | 309.52M |
| June 30, 2019 | 334.02M |
| March 31, 2019 | 170.01M |
| December 31, 2018 | 180.49M |
| September 30, 2018 | 169.67M |
| June 30, 2018 | 186.46M |
| March 31, 2018 | 94.53M |
| December 31, 2017 | 116.43M |
| September 30, 2017 | 82.58M |
| June 30, 2017 | 96.93M |
| March 31, 2017 | 49.87M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Theravance Biopharma, Inc. | 289.70M |
| BridgeBio Pharma, Inc. | -2.515B |
| Aprea Therapeutics, Inc. | 39.20M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 396.96M |
| Total Liabilities (Quarterly) | 316.60M |
| Debt to Equity Ratio | 3.343 |
| Current Ratio | 6.316 |
| Net Debt Paydown Yield | -2.66% |